Krystal Biotech Announces Second Quarter 2022 Financial Results and Reports Updates on Operational Progress

Go back to Krystal Biotech Announces Second Quarter 2022 Financial Results and Reports Updates on Operational Progress

Krystal Biotech, Inc. (KRYS) Misses Q2 EPS by 9c

August 8, 2022 7:09 AM EDT

Krystal Biotech, Inc. (NASDAQ: KRYS) reported Q2 EPS of ($1.10), $0.09 worse than the analyst estimate of ($1.01).

For earnings history and earnings-related data on Krystal Biotech, Inc. (KRYS) click here.

... More